Nektar Restructuring Ends Bempeg Ambitions, Cuts Staff By 70%

 
• By Joseph Haas

Following termination of its immuno-oncology partnership with Bristol, Nektar is paring operations, closing its India site and focusing on mid-stage NKTR-358, partnered with Lilly, and NKTR-255.

Restructure
Nektar undertakes a significant restructuring it alluded to a month earlier • Source: Alamy

More from Strategy

More from Business